Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes

A Kanakkanthara, A. Wilmes, A O'Brate, D Escuin, A Chan, A Gjyrezi, J Crawford, P Rawson, B Kivell, PT Northcote, E Hamel, P Giannakakou, JH Miller

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1419
Number of pages1429
JournalMolecular Cancer Therapeutics
Publication statusPublished - 2011

Cite this